PAIN TRIGGERS
Required doctor visits every 3 months for stable long-term meds despite 10 years of use
Pharmacies frequently out of stock requiring multiple calls, price checks, and prescription transfers
SaaS· ADHD adults on long-term stimulant medicationPain 8.00/10WTP 7.0/10Market 9.0/10Validation 8.0Confidence 82%May 22, 2026
StableMed: Real-Time ADHD Refill Coordinator
ADHD patients endure mandatory 3-month doctor visits for stable long-term meds, frequent pharmacy stockouts requiring dozens of calls, slow communication, and high costs from high-deductible plans.
adhdautomationchronic-carehealthcaremedication-managementmental-healthproductivitysaas
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
ADHD patients struggle with bureaucratic hurdles, frequent doctor visits, pharmacy stock shortages, and poor communication when refilling long-term medications like guanfacine and Adderall.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
Extremely frustrated about getting medication
ADHD23
Extremely frustrated about getting medication
ADHD23
I’ve used express scripts and it’s been a lifesaver
commentI’ve used express scripts and it’s been a lifesaver. They’ve never delayed or been out of stock for my meds. You can get it “filled” early to account for shipping times
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
ADHD adults on long-term stimulant medicationA D H D Adults On Long Term Stimulants
Adults with stable long-term ADHD prescriptions (e.g. Adderall, guanfacine) who manage multiple meds but face repeated bureaucratic and logistical barriers to consistent refills.
Context
Reliably and efficiently obtain stable ADHD and depression medications with minimal administrative burden, cost, and time spent on calls and transfers.
Manually calling multiple pharmacies to check stock and pricing before transferring prescriptions
Using mail-order pharmacies like Express Scripts for reliability
Current Workarounds
Manually calling multiple pharmacies to check stock and pricing
Coordinating prescription transfers between pharmacies and doctors
Using mail-order like Express Scripts for reliability
Attending required quarterly doctor visits despite stability
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
3-month doctor visit requirement for stable long-term prescriptions
No transparent real-time pharmacy stock and pricing information
Slow or unresponsive communication channels with doctors and pharmacies
Lack of automatic delivery or longer supply options for controlled substances
OPPORTUNITY & VALUE
Why Now
Repeated complaints about quarterly doctor visits for stable meds and time-consuming pharmacy stock hunts across multiple users.
Value Proposition
Hyper-focused on controlled ADHD stimulants with aggregated live inventory visibility and workflow automation that general pharmacy apps and mail-order services lack.
Product Direction
A dedicated web and mobile platform that aggregates real-time pharmacy stock and pricing for ADHD medications, automates transfer requests, and provides a streamlined portal for doctor refill approvals and communication.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$19/moIndividual user with unlimited refills
Model
SaaS subscription
WILLINGNESS TO PAY
Users already pay for Express Scripts reliability and waste 30+ minutes per call cycle plus high deductible visit costs; signals show strong frustration with current process and desire for stable supply solutions.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Reliable ADHD meds without endless pharmacy calls or unnecessary doctor visits.”
A dedicated web and mobile platform that aggregates real-time pharmacy stock and pricing for ADHD medications, automates transfer requests, and provides a streamlined portal for doctor refill approvals and communication.
Core Features
Real-time stock and price checker across local pharmacies
One-click prescription transfer requests
Secure messaging portal for doctor refill approvals
Automated refill reminders with status tracking
Weekly Roadmap
1
W1-W2
Core database and stock checker MVP functional for single user testing.
- •Build pharmacy database schema for ADHD meds
- •Implement manual stock entry UI for initial testing
- •User auth and basic profile setup
2
W3-W4
End-to-end refill request flow completed.
- •Add prescription upload and transfer request form
- •Build doctor messaging interface
- •Create refill status dashboard
3
W5
Internal testing and basic automation ready with beta users.
- •Add reminder notifications system
- •Test with 5-10 ADHD community volunteers
- •HIPAA basic compliance audit
4
W6
Public beta launch and first paid conversions.
- •Deploy subscription billing via Stripe
- •Launch in key Reddit ADHD communities
- •Gather feedback and track usage metrics
Launch Strategy
Launch in r/ADHD, r/ADHDers, and r/AdultADHD communities with targeted ads and partnerships with existing telehealth ADHD providers.
RISKS & ASSUMPTIONS
Top Risks
Controlled substance regulations
Strict rules around ADHD stimulants may limit data sharing and automation features, requiring careful legal compliance.
Pharmacy data integration
Real-time stock information is fragmented and pharmacies may not provide reliable APIs or updates.
User acquisition in sensitive health space
Building trust with privacy-conscious ADHD patients will require strong HIPAA compliance signaling.
Doctor portal adoption
Busy providers may resist adding another communication channel for refills.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 8/10 against 4 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
Why this matters for SaaS founders
It sits at the intersection of "adhd", "automation", "chronic-care", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "StableMed: Real-Time ADHD Refill Coordinator" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for adhd?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.